OasisLMS

For the most timely topics and latest surgical techniques in urology, you won t want to miss the 2015 AUA Update Series the AUA s most popular self-study CME product.

• Resident
• Urologist

After completing all 40 lessons, participants, will be able to apply their knowledge and competencies on the urologic topics covered in each article. Each of the 40 lessons has a specific objective specific to the related article.

Planner Disclosures:
Elspeth Marguerita McDougall, MD

Nothing to disclose

J. Kellogg Parsons, MD

AMS: Meeting Participant or Lecturer; Sophiris: Consultant or Advisor; Watson: Consultant or Advisor; Myraid: Consultant or Advisor

Tracey Krupski, MD

Nothing to disclose

Update Series Advisory Committee:
Arthur L. Burnett II, MD

Endo Pharmaceuticals, PFIZER, NIH, Auxilium Inc., American Medical Systems, Coloplast, Reflexonic LLC, Acorda Therapeutics, VIVUS: Scientific Study/Trial; Genomic Health Inc.: Consultant/Advisor; Andrology, International Urology and Nephrology, European Urology, Practical Reviews in Urology, Journal of Sexual Medicine: Health Publishing; New England Research Institute: Steering Committee; Center for Intimacy after Cancer Therapy: Leadership Position

Peter R. Carroll, MD

NIH, Department of Defense, Myriad Genetics: Scientific Study/Trial; Genomic Health: Consultant/ Advisor, Scientific Study/Trial; Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Janssen Pharmaceutical Companies, Intuitive Surgical Inc.: Lecturer

E. Ann Gormley, MD

National Institute of Health, NIDDK: Scientific Study/Trial

Kevin T. McVary, MD

Watson Pharmaceuticals: Consultant/Advisor; Neotract, Lilly/ICOS, NxThera: Consultant/Advisor, Scientific Study/Trial; NIDDK: Other

J. Curtis Nickel, MD

Lilly, GlaxoSmithKline: Consultant/Advisor, Scientific Study/Trial; NIH, NIDDK, Canadian Institute of Health Research (CIHR), Johnson and Johnson, Taris, Pfizer: Scientific Study/Trial; Astellas, Trillium Therapeutics, Farr Laboratories, Triton, Auxillium, Ferring: Consultant/Advisor

David F. Penson, MD, MPH

Nothing to disclose

Deborah F. Polly (AUA Staff)

Nothing to disclose

Michael L. Ritchey, MD

Nothing to disclose

Sheila Stark, PhD (AUA Staff)

Nothing to disclose

Ian M. Thompson Jr, MD

SWOG: Leadership Position, Scientific Study/Trial; Cancer Prevention and Research Institute of Texas, National Cancer Institute: Grant Funding

J. Stuart Wolf, Jr, MD

Endourological Society: Leadership Position; Urology Times, Journal of Endourology, Urologic Oncology, UroToday: Health Publishing

This self-study continuing medical education activity is designed to provide urologists, Board candidates and/or residents affordable and convenient access to the most recent developments and techniques in urology.

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring material for a maximum of 40.0 AMA PRA Category 1 Credits^TM.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME enduring material activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor and/or Education Content Review Committee or its subgroup.
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is feltto be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission: Reproduction of written materials developed for this AUA activity is prohibited without the written permission fromindividual authors and the American Urological Association.

Peer Review: Peer review is the principle mechanism by which the quality of the AUA Update Series content is judged by the AUA Update Series Advisory Board.

Released date: Month, 2015
Expiration date: Month, 2018

AUAER Privacy and Confidentiality Policy
www.auanet.org/cme/onllneeduconf.cfm
Email the AUA Office of Education with any questions at cme@auanet.org
2015 American Urological Association,
Linthicum, Maryland